Vazirani Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Vazirani Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-125,000	Closed	-$790K	–	24
2022 Q4	$790K	Buy	+125,000	New	+$692K	1.34%	20

Vazirani Asset Management's FSTX Position: Q1 2023 in Review

Vazirani Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 125,000 shares — an estimated $790K sold.

Vazirani Asset Management first reported a position in FSTX in Q4 2022 and held it in 1 quarter. The position peaked at $790K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Vazirani Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Vazirani Asset Management sold 125,000 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $790K.
Vazirani Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Vazirani Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $790K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Vazirani Asset Management's 13F filing for Q1 2023, filed 15 May 2023.